Cargando…

Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach

OBJECTIVE: Vaccines are utilized to prevent the severity of illnesses like the COVID-19 virus. Currently, there are a lot of COVID-19 vaccines available in the market like Pfizer, Moderna, AstraZeneca, Johnson and Johnson, and Sinovac. This research aimed to analyze the preference on the existing va...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Ardvin Kester S., Prasetyo, Yogi Tri, Lagura, Fae Coleen, Ramos, Rochelle Nicole, Salazar, Jose Ma Luis, Sigua, Keenan Mark, Villas, Jomy Anne, Chuenyindee, Thanatorn, Nadlifatin, Reny, Persada, Satria Fadil, Thana, Kriengkrai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293378/
https://www.ncbi.nlm.nih.gov/pubmed/35874794
http://dx.doi.org/10.1016/j.puhip.2022.100300
_version_ 1784749616832446464
author Ong, Ardvin Kester S.
Prasetyo, Yogi Tri
Lagura, Fae Coleen
Ramos, Rochelle Nicole
Salazar, Jose Ma Luis
Sigua, Keenan Mark
Villas, Jomy Anne
Chuenyindee, Thanatorn
Nadlifatin, Reny
Persada, Satria Fadil
Thana, Kriengkrai
author_facet Ong, Ardvin Kester S.
Prasetyo, Yogi Tri
Lagura, Fae Coleen
Ramos, Rochelle Nicole
Salazar, Jose Ma Luis
Sigua, Keenan Mark
Villas, Jomy Anne
Chuenyindee, Thanatorn
Nadlifatin, Reny
Persada, Satria Fadil
Thana, Kriengkrai
author_sort Ong, Ardvin Kester S.
collection PubMed
description OBJECTIVE: Vaccines are utilized to prevent the severity of illnesses like the COVID-19 virus. Currently, there are a lot of COVID-19 vaccines available in the market like Pfizer, Moderna, AstraZeneca, Johnson and Johnson, and Sinovac. This research aimed to analyze the preference on the existing vaccine attributes of COVID-19. STUDY DESIGN: Specifically, this study considered 7 attributes such as cost, brand, recommendations, efficacy, side effects, vaccine type, and dose. METHODS: A conjoint analysis with orthogonal design was utilized and 865 respondents were participated. RESULTS: The result showed that consumers considered brand as the highest attribute, specifically Pfizer and Moderna among other brands. Moreover, the efficacy of 90% and higher were the preferred vaccine with 1 in 100 patient side effects reported. It was seen that safety and effectiveness is the priority in choosing a COVID-19 vaccine. Interestingly, the knowledge and understanding of the COVID-19 vaccine was found to drive consumer's preference for the vaccines available. CONCLUSIONS: The findings of this study could be utilized by the government to increase the willingness to be vaccinated. Lastly, the result of this study would pave a way to promote herd immunity to help fight the COVID-19 pandemic worldwide.
format Online
Article
Text
id pubmed-9293378
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92933782022-07-19 Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach Ong, Ardvin Kester S. Prasetyo, Yogi Tri Lagura, Fae Coleen Ramos, Rochelle Nicole Salazar, Jose Ma Luis Sigua, Keenan Mark Villas, Jomy Anne Chuenyindee, Thanatorn Nadlifatin, Reny Persada, Satria Fadil Thana, Kriengkrai Public Health Pract (Oxf) Original Research OBJECTIVE: Vaccines are utilized to prevent the severity of illnesses like the COVID-19 virus. Currently, there are a lot of COVID-19 vaccines available in the market like Pfizer, Moderna, AstraZeneca, Johnson and Johnson, and Sinovac. This research aimed to analyze the preference on the existing vaccine attributes of COVID-19. STUDY DESIGN: Specifically, this study considered 7 attributes such as cost, brand, recommendations, efficacy, side effects, vaccine type, and dose. METHODS: A conjoint analysis with orthogonal design was utilized and 865 respondents were participated. RESULTS: The result showed that consumers considered brand as the highest attribute, specifically Pfizer and Moderna among other brands. Moreover, the efficacy of 90% and higher were the preferred vaccine with 1 in 100 patient side effects reported. It was seen that safety and effectiveness is the priority in choosing a COVID-19 vaccine. Interestingly, the knowledge and understanding of the COVID-19 vaccine was found to drive consumer's preference for the vaccines available. CONCLUSIONS: The findings of this study could be utilized by the government to increase the willingness to be vaccinated. Lastly, the result of this study would pave a way to promote herd immunity to help fight the COVID-19 pandemic worldwide. Elsevier 2022-07-19 /pmc/articles/PMC9293378/ /pubmed/35874794 http://dx.doi.org/10.1016/j.puhip.2022.100300 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Research
Ong, Ardvin Kester S.
Prasetyo, Yogi Tri
Lagura, Fae Coleen
Ramos, Rochelle Nicole
Salazar, Jose Ma Luis
Sigua, Keenan Mark
Villas, Jomy Anne
Chuenyindee, Thanatorn
Nadlifatin, Reny
Persada, Satria Fadil
Thana, Kriengkrai
Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach
title Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach
title_full Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach
title_fullStr Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach
title_full_unstemmed Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach
title_short Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach
title_sort young adult preference analysis on the attributes of covid-19 vaccine in the philippines: a conjoint analysis approach
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293378/
https://www.ncbi.nlm.nih.gov/pubmed/35874794
http://dx.doi.org/10.1016/j.puhip.2022.100300
work_keys_str_mv AT ongardvinkesters youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach
AT prasetyoyogitri youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach
AT lagurafaecoleen youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach
AT ramosrochellenicole youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach
AT salazarjosemaluis youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach
AT siguakeenanmark youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach
AT villasjomyanne youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach
AT chuenyindeethanatorn youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach
AT nadlifatinreny youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach
AT persadasatriafadil youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach
AT thanakriengkrai youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach